Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behringer

Showing results (1151-1160 of 1,187) with videos related to

Pageof 119
Sort By:
Nature Food|May 2, 2023
Sustainable aquaculture through the One Health lensG D Stentiford, I J Bateman, S J Hinchliffe, et al.
Blood Neoplasia|June 2, 2025
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trialUlrich Dührsen, Andreas Bockisch, Bernd Hertenstein, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Rational engineering of facultative anaerobiosis enables commensal survival in the oxygenated gutAbigail E Rose, Madison Langford-Butler, Luisella Spiga, et al.
Clinical Nutrition ESPEN|June 26, 2025
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010)Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Ingeborg Roetzer, et al.
The Lancet. Oncology|July 13, 2025
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trialJustin Ferdinandus, Gundolf Schneider, Alden Moccia, et al.
Nature Communications|February 18, 2022
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Vidhya M Ravi, Nicolas Neidert, Paulina Will, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation StudyP Scherer, I K Penner, A Rohr, et al.
Elife|October 17, 2018
Firefly genomes illuminate parallel origins of bioluminescence in beetlesTimothy R Fallon, Sarah E Lower, Ching-Ho Chang, et al.
Plos One|October 11, 2012
R26R-GR: a Cre-activable dual fluorescent protein reporter mouseYou-Tzung Chen, Ming-Shian Tsai, Tsung-Lin Yang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 5, 2022
Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysisAnna Slagman, Mareen Pigorsch, Felix Greiner, et al.
Pageof 119

Showing results (1151-1160 of 1,187) with videos related to

Sort By:
Pageof 119
Nature Food|May 2, 2023
Sustainable aquaculture through the One Health lensG D Stentiford, I J Bateman, S J Hinchliffe, et al.
Blood Neoplasia|June 2, 2025
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trialUlrich Dührsen, Andreas Bockisch, Bernd Hertenstein, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Rational engineering of facultative anaerobiosis enables commensal survival in the oxygenated gutAbigail E Rose, Madison Langford-Butler, Luisella Spiga, et al.
Clinical Nutrition ESPEN|June 26, 2025
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010)Thorsten Oliver Goetze, Ralf-Dieter Hofheinz, Ingeborg Roetzer, et al.
The Lancet. Oncology|July 13, 2025
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trialJustin Ferdinandus, Gundolf Schneider, Alden Moccia, et al.
Nature Communications|February 18, 2022
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Vidhya M Ravi, Nicolas Neidert, Paulina Will, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation StudyP Scherer, I K Penner, A Rohr, et al.
Elife|October 17, 2018
Firefly genomes illuminate parallel origins of bioluminescence in beetlesTimothy R Fallon, Sarah E Lower, Ching-Ho Chang, et al.
Plos One|October 11, 2012
R26R-GR: a Cre-activable dual fluorescent protein reporter mouseYou-Tzung Chen, Ming-Shian Tsai, Tsung-Lin Yang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 5, 2022
Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysisAnna Slagman, Mareen Pigorsch, Felix Greiner, et al.
Pageof 119